Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
-
* Corresponding author: Tore Saxne tore.saxne@reum.lu.se
Arthritis Res Ther 2003, 5:R181-R185 doi:10.1186/ar760
No comments have yet been made on this article.